Management of Ventricular Bigeminy

Initial Evaluation

A thorough cardiac assessment should be performed to rule out structural heart disease, which would significantly alter management, according to the American Heart Association 1
A detailed history should be obtained, focusing on potential cardiac symptoms, family history of sudden cardiac death, cardiomyopathy, or channelopathies, medication use, and substance use that could trigger arrhythmias, as recommended by the American College of Cardiology 1
A 12-lead ECG should be conducted to look for signs of structural heart disease or channelopathies, assess QRS morphology, and evaluate for valvular abnormalities, as suggested by the American Heart Association 1

Echocardiography is essential to rule out structural heart disease, assess left ventricular function, and evaluate for valvular abnormalities, according to the European Society of Cardiology 2
24-hour Holter monitoring may be considered to identify any more complex arrhythmias, correlate symptoms with arrhythmia occurrence, and quantify PVC burden, as recommended by the American Heart Association 1
Exercise stress testing may be valuable to assess if PVCs increase or decrease with exercise, rule out exercise-induced more serious arrhythmias, and evaluate for underlying coronary artery disease, as suggested by the American College of Cardiology 1

Reassurance and observation is the mainstay of treatment for truly asymptomatic patients with normal cardiac structure and function, according to the American Heart Association 1
Lifestyle modifications, such as reducing potential triggers like caffeine, alcohol, and stimulant consumption, optimizing sleep patterns, and managing stress, are recommended, as suggested by the American College of Cardiology 1

Clinical evaluation every 6-12 months is recommended to reassess for development of symptoms, changes in arrhythmia pattern, and development of structural heart disease, according to the European Society of Cardiology 2
Repeat echocardiography every 2-3 years may be considered to monitor for development of structural changes, particularly if PVC burden is high, as recommended by the European Society of Cardiology 2

If PVC burden is very high (>15-20% of total beats), closer monitoring may be warranted due to risk of developing PVC-induced cardiomyopathy, even in asymptomatic patients, according to the American Heart Association 1
Intervention should be considered if symptoms attributable to the arrhythmia, decline in left ventricular function, very high PVC burden, or complex ventricular arrhythmias develop, as recommended by the American College of Cardiology 1